Literature DB >> 17764624

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Karen Marder.   

Abstract

Entities:  

Year:  2007        PMID： 17764624     DOI： 10.1007/s11910-007-0056-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  13 in total

1.  Advances in the treatment of behavioral disturbances in Alzheimer's disease.

Authors:  J L Cummings; D Knopman
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 3.  The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Authors:  C Ballard; J Waite
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

5.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Authors:  Lon S Schneider; Karen Dagerman; Philip S Insel
Journal:  Am J Geriatr Psychiatry       Date:  2006-03       Impact factor: 4.105

6.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Authors:  Philip S Wang; Sebastian Schneeweiss; Jerry Avorn; Michael A Fischer; Helen Mogun; Daniel H Solomon; M Alan Brookhart
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

7.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

8.  The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.

Authors:  Ira Katz; Peter-Paul de Deyn; Jacobo Mintzer; Andrew Greenspan; Young Zhu; Henry Brodaty
Journal:  Int J Geriatr Psychiatry       Date:  2007-05       Impact factor: 3.485

Review 9.  Valproic acid for agitation in dementia.

Authors:  E T Lonergan; M Cameron; J Luxenberg
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients.

Authors:  C Shea; C MacKnight; K Rockwood
Journal:  Int Psychogeriatr       Date:  1998-09       Impact factor: 3.878
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.